J. Goldman & CO LP Rezolute, Inc. Transaction History
J. Goldman & CO LP
- $3.53 Billion
- Q4 2024
A detailed history of J. Goldman & CO LP transactions in Rezolute, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 232,627 shares of RZLT stock, worth $1.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
232,627Holding current value
$1.1 Million% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$53.6 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$13.6 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13.3 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$12 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$11 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $184M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...